_xsnx39s-thin-film-solar-technology-moneytv-with-donald-baillargeon-preview-1.jpg "XSNX's Thin-Film Solar Technology- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview 1")
Gallery_xsnx39s-thin-film-solar-technology-moneytv-with-donald-baillargeon-preview-3.jpg "XSNX's Thin-Film Solar Technology- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview 3")
Gallery_xsnx39s-thin-film-solar-technology-moneytv-with-donald-baillargeon-preview-hqdefault.jpg "XSNX's Thin-Film Solar Technology- MoneyTV with Donald Baillargeon from xsnx Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 10 minutes 58 seconds
👁 View: 67 times
Play Audio:👁 View: 67 times
Description:
MoneyTV with Donald Baillargeon
MoneyTV with Donald Baillargeon
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_xsnx-discusses-pr-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_xsnx-funding-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_orphan-drug-status-moneytv-with-donald-baillargeon.webp "On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCQB: XSNX) CEO Dr. Dwain Irvin announced their treatment has achieved orphan drug status with the FDA.")
_kirkiimad-ily-xsnx-mscx-remix.webp "XSNX MSCX")
_xsnx-funding-moneytv-with-donald-baillargeon.webp "On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCPINK: XSNX) CEO Dr. Dwain Irvin and CFO Neil Laird discussed funding requirements and successes.")
_xsnx-unveils-cigs-solar-cell-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_xsnx-progress-moneytv-with-donald-baillargeon.webp "MoneyTV with Donald Baillargeon")
_novaccess-global-inc-moneytv-with-donald-baillargeon.webp "On MoneyTV with Donald Baillargeon, NovAccess Global, Inc. (OTCPINK: XSNX) CEO Dr. Dwain Irvin said StemVax is submitting an IND application for FDA approval to begin a Phase IIa clinical trial.")
_xsnx-discusses-pr-moneytv-with-donald-baillargeon.jpg)
_xsnx-funding-moneytv-with-donald-baillargeon.jpg)
_orphan-drug-status-moneytv-with-donald-baillargeon.jpg)
_kirkiimad-ily-xsnx-mscx-remix.jpg)
_xsnx-funding-moneytv-with-donald-baillargeon.jpg)
_xsnx-unveils-cigs-solar-cell-moneytv-with-donald-baillargeon.jpg)
_xsnx-progress-moneytv-with-donald-baillargeon.jpg)
_novaccess-global-inc-moneytv-with-donald-baillargeon.jpg)
![[+]](/images/menu.gif){kind=small}